BioFish Holding AS Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	44.77	47.68	20.24	18.33	30.92
Revenue Growth (YoY)	22.98%	135.55%	10.44%	-40.73%	-
Cost of Revenue	30.51	42.83	21.23	11.4	19.37
Gross Profit	14.25	4.85	-0.98	6.93	11.55
Selling, General & Admin	14.81	7.56	5.02	2.12	4.3
Other Operating Expenses	9.07	6.7	9.24	12.28	-
Operating Expenses	36.21	20.51	14.77	14.8	4.72
Operating Income	-21.96	-15.66	-15.75	-7.87	6.83
Interest Expense	-4.83	-1.77	-0.88	-0.13	-
Interest & Investment Income	-	-	-	0.09	1.94
Other Non Operating Income (Expenses)	-0.4	-0.4	0.15	-0	-
Pretax Income	-27.13	-17.83	-16.48	-7.91	8.77
Income Tax Expense	0	0	-1.59	-2.12	1.96
Net Income	-27.14	-17.83	-14.89	-5.79	6.81
Net Income to Common	-27.14	-17.83	-14.89	-5.79	6.81
Shares Outstanding (Basic)	102	88	13	-	-
Shares Outstanding (Diluted)	102	88	13	-	-
Shares Change (YoY)	-	559.17%	-	-	-
EPS (Basic)	-0.27	-0.20	-1.11	-	-
EPS (Diluted)	-0.27	-0.20	-1.11	-	-
Free Cash Flow	-32.83	-64.77	-44.6	-100.82	-
Free Cash Flow Per Share	-0.32	-0.73	-3.33	-	-
Gross Margin	31.84%	10.18%	-4.85%	37.80%	37.35%
Operating Margin	-49.06%	-32.83%	-77.78%	-42.95%	22.09%
Profit Margin	-60.62%	-37.39%	-73.56%	-31.57%	22.04%
Free Cash Flow Margin	-73.34%	-135.84%	-220.32%	-550.03%	-
EBITDA	-9.63	-9.41	-15.25	-7.47	7.25
EBITDA Margin	-21.51%	-19.73%	-75.31%	-40.77%	23.46%
D&A For EBITDA	12.33	6.25	0.5	0.4	0.42
EBIT	-21.96	-15.66	-15.75	-7.87	6.83
EBIT Margin	-49.06%	-32.83%	-77.78%	-42.95%	22.09%
Effective Tax Rate	-	-	-	-	22.30%
Revenue as Reported	-	-	-	18.33	-

Source: S&P Capital IQ. Standard template. Financial Sources.